424 related articles for article (PubMed ID: 23481561)
1. Profile of regulatory T cells and interferon γ secretion in the tumor-draining lymph node from mouse Hepa1-6 cells.
Wang LK; Kuang M; Hua YP; He Q; Chen B; Wang Y; Peng BG
J Surg Res; 2013 Aug; 183(2):900-6. PubMed ID: 23481561
[TBL] [Abstract][Full Text] [Related]
2. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
[TBL] [Abstract][Full Text] [Related]
3. Increased tumor-infiltrating CD8(+)Foxp3(+) T lymphocytes are associated with tumor progression in human gastric cancer.
Peng LS; Zhuang Y; Shi Y; Zhao YL; Wang TT; Chen N; Cheng P; Liu T; Liu XF; Zhang JY; Zuo QF; Mao XH; Guo G; Lu DS; Yu PW; Zou QM
Cancer Immunol Immunother; 2012 Nov; 61(11):2183-92. PubMed ID: 22729557
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of CD4+ CD25+ regulatory T-cells detection in tumor-draining lymph nodes of nonsmall cell lung cancer patients].
Su YJ; Ren K; Li H; Ren XB; Wang CL
Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):922-6. PubMed ID: 18478932
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral interleukin-21 increases antitumor immunity, tumor-infiltrating CD8+ T-cell density and activity, and enlarges draining lymph nodes.
Søndergaard H; Galsgaard ED; Bartholomaeussen M; Straten PT; Odum N; Skak K
J Immunother; 2010 Apr; 33(3):236-49. PubMed ID: 20445344
[TBL] [Abstract][Full Text] [Related]
7. Different cytokine profiles released by CD4+ and CD8+ tumor-draining lymph node cells involved in mediating tumor regression.
Aruga A; Aruga E; Cameron MJ; Chang AE
J Leukoc Biol; 1997 Apr; 61(4):507-16. PubMed ID: 9103238
[TBL] [Abstract][Full Text] [Related]
8. [Changes of regulatory T cell number in hepatocellular carcinoma-bearing mice and its relationship with tumor growth].
Zhang P; Zhang LN; Zhu FL; Wang Q; Wang XY; Li HY; Liu CM; Gao F; Liu CH
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):342-5. PubMed ID: 17892128
[TBL] [Abstract][Full Text] [Related]
9. Potential role of plasmacytoid dendritic cells for FOXP3+ regulatory T cell development in human colorectal cancer and tumor draining lymph node.
Gai XD; Song Y; Li C; Lei YM; Yang B
Pathol Res Pract; 2013 Dec; 209(12):774-8. PubMed ID: 24080284
[TBL] [Abstract][Full Text] [Related]
10. Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response.
Thomas SN; Vokali E; Lund AW; Hubbell JA; Swartz MA
Biomaterials; 2014 Jan; 35(2):814-24. PubMed ID: 24144906
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effects of IL-12 and IL-18 in skewing tumor-reactive T-cell responses towards a type 1 pattern.
Li Q; Carr AL; Donald EJ; Skitzki JJ; Okuyama R; Stoolman LM; Chang AE
Cancer Res; 2005 Feb; 65(3):1063-70. PubMed ID: 15705908
[TBL] [Abstract][Full Text] [Related]
12. CD4+CD25+Foxp3+ regulatory T cells are dispensable for controlling CD8+ T cell-mediated lung inflammation.
Tosiek MJ; Gruber AD; Bader SR; Mauel S; Hoymann HG; Prettin S; Tschernig T; Buer J; Gereke M; Bruder D
J Immunol; 2011 Jun; 186(11):6106-18. PubMed ID: 21518973
[TBL] [Abstract][Full Text] [Related]
13. Immune compartmentalization of T cell subsets in chemically-induced breast cancer.
Fahmi T; Esendagli G; Yilmaz G; Kansu E; Guc D
Scand J Immunol; 2010 Oct; 72(4):339-48. PubMed ID: 20883319
[TBL] [Abstract][Full Text] [Related]
14. Central role of tumor-associated CD8+ T effector/memory cells in restoring systemic antitumor immunity.
Kilinc MO; Gu T; Harden JL; Virtuoso LP; Egilmez NK
J Immunol; 2009 Apr; 182(7):4217-25. PubMed ID: 19299720
[TBL] [Abstract][Full Text] [Related]
15. Combination of SLC administration and Tregs depletion is an attractive strategy for targeting hepatocellular carcinoma.
Chen L; Zhou S; Qin J; Hu H; Ma H; Liu B; Wang X; Ma J; Ye S; Zhong C; Zhou G; Liang C
Mol Cancer; 2013 Dec; 12(1):153. PubMed ID: 24304581
[TBL] [Abstract][Full Text] [Related]
16. [Tumor infiltrating regulatory T cells in human breast cancer and associated draining lymph nodes: an in-situ analysis].
Wang HY; Shi QF; Sun Y; He JJ; Wang YL
Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):95-100. PubMed ID: 23710915
[TBL] [Abstract][Full Text] [Related]
17. CD8+ Foxp3+ T cells share developmental and phenotypic features with classical CD4+ Foxp3+ regulatory T cells but lack potent suppressive activity.
Mayer CT; Floess S; Baru AM; Lahl K; Huehn J; Sparwasser T
Eur J Immunol; 2011 Mar; 41(3):716-25. PubMed ID: 21312192
[TBL] [Abstract][Full Text] [Related]
18. Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients.
Yang ZQ; Yang ZY; Zhang LD; Ping-Bie ; Wang SG; Ma KS; Li XW; Dong JH
Hum Immunol; 2010 Dec; 71(12):1180-6. PubMed ID: 20870003
[TBL] [Abstract][Full Text] [Related]
19. TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4(+)CD25 (+) Treg apoptosis.
Diao Z; Shi J; Zhu J; Yuan H; Ru Q; Liu S; Liu Y; Zheng D
Cancer Immunol Immunother; 2013 Apr; 62(4):653-63. PubMed ID: 23143747
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of allogenic T-cell cytotoxicity by hepatic stellate cell via CD4⁺ CD25⁺ Foxp3⁺ regulatory T cells in vitro.
Wu TJ; Wang YC; Wu TH; Lee CF; Chan KM; Lee WC
Transplant Proc; 2012 May; 44(4):1055-9. PubMed ID: 22564624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
